These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 12161726)

  • 1. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
    Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature.
    Haliloglu NU; Yesilirmak Z; Erden A; Erden I
    Dentomaxillofac Radiol; 2008 Mar; 37(3):161-6. PubMed ID: 18316508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
    Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
    BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbito-cerebral mucormycosis: a treatment dilemma.
    Jeevanan J; Gendeh BS; Faridah HA; Vikneswaran T
    Med J Malaysia; 2006 Mar; 61(1):106-8. PubMed ID: 16708746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
    Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
    Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy.
    Thajeb P; Thajeb T; Dai D
    Scand J Infect Dis; 2004; 36(9):643-8. PubMed ID: 15370650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
    Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
    J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rhino-orbito-cerebral mucormycosis].
    Derkaoui A; Khatouf M
    Pan Afr Med J; 2012; 13():69. PubMed ID: 23396825
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival factors in rhino-orbital-cerebral mucormycosis.
    Yohai RA; Bullock JD; Aziz AA; Markert RJ
    Surv Ophthalmol; 1994; 39(1):3-22. PubMed ID: 7974189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.
    Songu M; Unlu HH; Gunhan K; Ilker SS; Nese N
    Am J Rhinol; 2008; 22(1):98-103. PubMed ID: 18284868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
    Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
    Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinocerebral mucormycosis with orbital and intracranial extension: a case report and review of optimum management.
    Munir N; Jones NS
    J Laryngol Otol; 2007 Feb; 121(2):192-5. PubMed ID: 17134533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variations in rhino-cerebral Mucor infection.
    Shpitzer T; Keller N; Wolf M; Goldschmied-Reouven A; Bahar G; Bahar I; Kronenberg J; Feinmesser R; Talmi YP
    Ann Otol Rhinol Laryngol; 2005 Sep; 114(9):695-8. PubMed ID: 16240932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of bilateral rhino-orbital cerebral mucormycosis.
    Lam SC; Yuen HKL
    Hong Kong Med J; 2019 Oct; 25(5):408-409. PubMed ID: 31761754
    [No Abstract]   [Full Text] [Related]  

  • 17. Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
    Vironneau P; Kania R; Morizot G; Elie C; Garcia-Hermoso D; Herman P; Lortholary O; Lanternier F;
    Clin Microbiol Infect; 2014 May; 20(5):O336-9. PubMed ID: 24118291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of rhino-orbital mucormycosis.
    Mohamed MS; Abdel-Motaleb HY; Mobarak FA
    Saudi Med J; 2015 Jul; 36(7):865-8. PubMed ID: 26108594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and factors affecting them in patients with rhino-orbito-cerebral mucormycosis.
    Kashkouli MB; Abdolalizadeh P; Oghazian M; Hadi Y; Karimi N; Ghazizadeh M
    Br J Ophthalmol; 2019 Oct; 103(10):1460-1465. PubMed ID: 30514712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rhino-orbito-cerebral mucormycosis: two case reports in the light of the literature].
    Kara M; Erdoğan H; Toroslu T; Akçalı A; Tatman Okun M; Reşorlu M; Dereköy FS
    Kulak Burun Bogaz Ihtis Derg; 2015; 25(5):295-301. PubMed ID: 26476519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.